Susquehanna International Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10K | Buy |
|
|||||
|
2025
Q1 | $3.42K | Sell |
|
|||||
|
2024
Q4 | $15.7K | Sell |
|
|||||
|
2024
Q3 | $180K | Sell |
|
|||||
|
2024
Q2 | $236K | Buy |
|
|||||
|
2024
Q1 | $89K | Sell |
|
|||||
|
2023
Q4 | $45.1K | Sell |
|
|||||
|
2023
Q3 | $130K | Sell |
|
|||||
|
2023
Q2 | $168K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $41.1K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $229K | Buy |
|
|||||
|
2022
Q1 | $165K | Sell |
|
|||||
|
2021
Q4 | $420K | Sell |
|
|||||
|
2021
Q3 | $1.16M | Buy |
|
|||||
|
2021
Q2 | $469K | Buy |
|
|||||
|
2021
Q1 | $271K | Sell |
|
|||||
|
2020
Q4 | $796K | Buy |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $878K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $611K | Buy |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $65K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $131K | Buy |
|